Does USTEKINUMAB Cause Congenital anomaly? 134 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Congenital anomaly have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.2% of all adverse event reports for USTEKINUMAB.
134
Reports of Congenital anomaly with USTEKINUMAB
0.2%
of all USTEKINUMAB reports
21
Deaths
8
Hospitalizations
How Dangerous Is Congenital anomaly From USTEKINUMAB?
Of the 134 reports, 21 (15.7%) resulted in death, 8 (6.0%) required hospitalization, and 5 (3.7%) were considered life-threatening.
Is Congenital anomaly Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 134 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Congenital anomaly?
OXYCODONE (683)
ACETAMINOPHEN\OXYCODONE (460)
ACETAMINOPHEN\HYDROCODONE (439)
TRAMADOL (348)
HYDROMORPHONE (341)
LEVETIRACETAM (334)
ONDANSETRON (334)
ABATACEPT (322)
BUPRENORPHINE (296)
MORPHINE (293)
Which USTEKINUMAB Alternatives Have Lower Congenital anomaly Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE